☰

Raymond D. Meng, Ph.D. - Publications

Affiliations: 
2001 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, Schwartz GK. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Research. 69: 573-82. PMID 19147571 DOI: 10.1158/0008-5472.CAN-08-2088  0.35
2001 McGarvey TW, Meng RD, Johnson O, El-Deiry W, Malkowicz SB. Growth inhibitory effect of p21 and p53 containing adenoviruses on transitional cell carcinoma cell lines in vitro and in vivo. Urologic Oncology. 6: 155-162. PMID 11418322 DOI: 10.1016/S1078-1439(00)00128-9  0.704
2001 Meng RD, El-Deiry WS. p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma. Experimental Cell Research. 262: 154-69. PMID 11139340 DOI: 10.1006/Excr.2000.5073  0.701
2001 McGarvey TW, Meng RD, Johnson O, El-Deiry W, Malkowicz SB. Growth inhibitory effect of p21 and p53 containing adenoviruses on transitional cell carcinoma cell lines in vitro and in vivo Urologic Oncology. 6: 155-162. DOI: 10.1016/S1078-1439(00)00128-9  0.643
2000 Meng RD, McDonald ER, Sheikh MS, Fornace AJ, El-Deiry WS. The TRAIL Decoy Receptor TRUNDD (DcR2, TRAIL-R4) Is Induced by Adenovirus-p53 Overexpression and Can Delay TRAIL-, p53-, and KILLER/DR5-Dependent Colon Cancer Apoptosis Molecular Therapy. 1: 130-144. PMID 10933923 DOI: 10.1006/Mthe.2000.0025  0.645
1999 Wu GS, Burns TF, McDonald ER, Meng RD, Kao G, Muschel R, Yen T, el-Deiry WS. Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest. Oncogene. 18: 6411-8. PMID 10597242 DOI: 10.1038/Sj.Onc.1203025  0.668
1999 Song S, MacLachlan TK, Meng RD, El-Deiry WS. Comparative gene expression profiling in response to p53 in a human lung cancer cell line. Biochemical and Biophysical Research Communications. 264: 891-5. PMID 10544026 DOI: 10.1006/Bbrc.1999.1598  0.679
1999 Maclachlan TK, Meng RD, El-Deiry WS. "p53: Twenty Years On" in Trieste, Italy, May 20-22, 1999. Journal of Cellular Physiology. 181: 371-4. PMID 10497316 DOI: 10.1002/(Sici)1097-4652(199911)181:2<371::Aid-Jcp19>3.0.Co;2-3  0.624
1999 Meng RD, Phillips P, El-Deiry WS. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. International Journal of Oncology. 14: 5-14. PMID 9863003 DOI: 10.3892/Ijo.14.1.5  0.622
1998 Meng RD, El-Deiry WS. Tumor suppressor gene therapy for cancer: from the bench to the clinic. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 1: 205-10. PMID 17092807 DOI: 10.1016/S1368-7646(98)80041-1  0.625
1998 Meng RD, Shih H, Prabhu NS, George DL, el-Deiry WS. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 4: 251-9. PMID 9516979  0.662
Show low-probability matches.